Gastrointestinal (GI) Endoscopy Devices - Global Strategic Business Report

The global market for Gastrointestinal (GI) Endoscopy Devices was valued at US$37.1 Billion in 2024 and is projected to reach US$49.9 Billion by 2030, growing at a CAGR of 5.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Gastrointestinal (GI) Endoscopy Devices Market - Key Trends and Drivers Summarized

The growth in the GI endoscopy devices market is driven by several factors, including technological advancements, the rising incidence of gastrointestinal diseases, and the growing preference for minimally invasive procedures. Technological innovations have played a pivotal role, with the integration of artificial intelligence in endoscopic imaging significantly enhancing diagnostic accuracy and speed, allowing for more precise detection of abnormalities. The development of disposable endoscopes has also been a major advancement, reducing the risk of cross-contamination and infection, which has further boosted their adoption in clinical settings. The increasing prevalence of colorectal cancer and other gastrointestinal cancers has underscored the need for regular screenings, contributing significantly to market growth. Additionally, lifestyle changes, such as poor dietary habits and sedentary lifestyles, have led to a surge in gastrointestinal disorders, thereby driving demand for endoscopic procedures. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising healthcare expenditures are creating new growth opportunities for the GI endoscopy devices market. As more regions gain access to advanced diagnostic tools and treatments, the demand for GI endoscopy devices is expected to continue its upward trajectory, driven by the need for effective, minimally invasive diagnostic and therapeutic solutions.

The market for GI endoscopy devices is experiencing significant growth, driven by the increasing prevalence of gastrointestinal diseases and the growing adoption of early diagnostic techniques. Gastrointestinal disorders rank among the most common health issues globally, affecting millions of people and imposing substantial healthcare costs. The global aging population is particularly vulnerable to these conditions, resulting in a heightened demand for diagnostic and therapeutic endoscopic procedures. Additionally, there is a growing awareness and acceptance of minimally invasive surgeries among both patients and healthcare providers, which has accelerated the adoption of GI endoscopy devices. Healthcare facilities, including hospitals and clinics, are investing heavily in state-of-the-art endoscopic equipment to enhance patient care, improve diagnostic accuracy, and reduce hospitalization times. This trend is further supported by favorable reimbursement policies in many regions, which incentivize healthcare providers to expand their endoscopic services. As a result, there is a notable increase in the utilization of advanced GI endoscopy devices in clinical settings worldwide.

Gastrointestinal (GI) endoscopy devices are critical in the medical field for diagnosing and treating various digestive system disorders. These devices encompass a broad spectrum of instruments, including flexible endoscopes, high-definition visualization systems, and an array of accessories such as biopsy forceps, polypectomy snares, and hemostatic devices. GI endoscopy facilitates minimally invasive examinations of the gastrointestinal tract, offering detailed, real-time imagery and videos of the esophagus, stomach, intestines, and colon. Recent technological advancements have significantly enhanced these devices, leading to the development of more sophisticated, flexible, and miniaturized endoscopes that improve diagnostic accuracy for conditions such as gastrointestinal cancers, ulcers, and inflammatory bowel diseases. Additionally, innovations like artificial intelligence (AI)-assisted image analysis, enhanced endoscope maneuverability, and improved imaging capabilities have revolutionized endoscopic procedures, making them more efficient and less invasive. These advancements have not only enhanced the diagnostic capabilities of GI endoscopy devices but have also improved patient comfort and outcomes.

Report Scope

The report analyzes the Gastrointestinal (GI) Endoscopy Devices market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.

Segments

Product Type (Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopes, GI Videoscopes, Other Product Types); Application (Hospitals, Clinics, Other Applications).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Endoscopic Retrograde Cholangiopancreatography Devices (ERCP) segment, which is expected to reach US$25.5 Billion by 2030 with a CAGR of a 5.3%. The Capsule Endoscopes segment is also set to grow at 5.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $9.9 Billion in 2024, and China, forecasted to grow at an impressive 8.5% CAGR to reach $10.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Gastrointestinal (GI) Endoscopy Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Gastrointestinal (GI) Endoscopy Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Gastrointestinal (GI) Endoscopy Devices Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Nutrition, Boston Scientific Corporation, Cardinal Health, Inc., ConMed Corporation, Cook Medical, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 32 companies featured in this Gastrointestinal (GI) Endoscopy Devices market report include:

• Abbott Nutrition
• Boston Scientific Corporation
• Cardinal Health, Inc.
• ConMed Corporation
• Cook Medical, Inc.
• Erbe Elektromedizin GmbH
• Johnson & Johnson
• Kimberly-Clark Corporation
• Medtronic, Inc.
• Olympus Corporation
• Ricoh Imaging Co., Ltd.
• Stryker Corporation
• Taewoong Medical Co., Ltd.